Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Business

AstraZeneca, Chi-Med take kidney cancer drug into final testing

LONDON (Reuters) - AstraZeneca and Hutchison China MediTech said on Thursday they had initiated a global late-stage clinical trial of the experimental drug savolitinib in a relatively rare type of kidney cancer.

The launch triggers a $5 million payment from AstraZeneca to the Shanghai-based drugmaker, which is listed in London and is known as Chi-Med. The move underscores Chi-Med's drive to bring modern Chinese drugs to the international market.

The Phase III study will test savolitinib in c-MET-driven papillary renal cell carcinoma.

(Reporting by Ben Hirschler, editing by David Evans)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
New York woman is excited to walk into Amex airport lounge for the first time—until some men start making fun of her: ‘I already was so insecure’
A New York influencer celebrates getting her first American Express Platinum card by checking out one of the credit card’s exclusive airport lounges. A group of men make a rude comment about her appearance that ruins her mood. She gets her revenge after another member recognizes her.
The Mary Sue
The Mary Sue
Menstrual pads and tampons can contain toxic substances – here’s what to know about this emerging health issue
About half of the global population menstruates at some point in their lives. Disposable products, such as tampons and pads, are some of the most popular products used around the globe to manage menstrual flow.
The Conversation
The Conversation
‘It’s not your house’: Homeowner floored after finding TikTok scammer trying to rent out the condo she owns
She found a video of her own home up for rent on TikTok.
We Got This Covered
We Got This Covered
“You have to go to a clinic”: Clavicular’s candid remarks about intimacy spark debate and laughter across the internet
Clavicular went viral after joking about intimacy during a podcast appearance, turning an awkward question into a widely shared clip. His humor sparked debate over authenticity, shock value, and internet fame. The streamer also dismissed viral slang tied to his name, calling it meaningless social media noise, while his mix…
The Times of India
The Times of India
Charli XCX: Popularity of Brat was ‘heavy, confusing and very vulnerable change’
The singer was speaking on BBC One’s The Graham Norton Show.
Evening Standard
Evening Standard
Can a rhythm be owned? What a reggaeton lawsuit reveals about how copyright misunderstands music
A little-known American lawsuit could end up reshaping popular music. A US federal court is preparing to rule on a landmark copyright dispute. At its centre is an interesting question: can a short rhythmic pattern – one that appears in thousands of reggaeton tracks – be owned?
The Conversation
The Conversation
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play